Adrenal function in patients treated with testosterone and fluorinated pyrimidines.
D015068:17-Ketosteroids / Q000652:urine; D000230:Adenocarcinoma / Q000188:drug therapy / Q000503:physiopathology*; D000305:Adrenal Cortex Hormones / Q000652:urine; D000311:Adrenal Glands / Q000503:physiopathology*; D000324:Adrenocorticotropic Hormone; D000368:Aged; D001943:Breast Neoplasms / Q000188:drug therapy / Q000503:physiopathology*; D002986:Clinical Trials as Topic; D005260:Female; D005467:Floxuridine / Q000627:therapeutic use*; D005472:Fluorouracil / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010912:Pituitary-Adrenal Function Tests; D012004:Rectal Neoplasms / Q000188:drug therapy / Q000503:physiopathology*; D018310:Sertoli-Leydig Cell Tumor / Q000188:drug therapy / Q000503:physiopathology*; D013274:Stomach Neoplasms / Q000188:drug therapy / Q000503:physiopathology*; D013739:Testosterone / Q000627:therapeutic use*
D015068:17-Ketosteroids; D000305:Adrenal Cortex Hormones; D005467:Floxuridine; D013739:Testosterone; D000324:Adrenocorticotropic Hormone; D005472:Fluorouracil